What is Instech Laboratories?
Instech Laboratories occupies a critical niche in the biomedical research ecosystem, specializing in the design and manufacture of high-precision laboratory research equipment. The company focuses on rodent infusion and sampling technologies, providing essential tools for oral gavage, intravenous drug delivery, and blood sampling. By prioritizing the 3Rs—Replacement, Reduction, and Refinement—Instech aligns its product development with global standards for animal welfare. Their portfolio serves as a cornerstone for researchers conducting complex studies on mice and rats, ensuring that data integrity is maintained through reliable, efficient, and ethically sound instrumentation.
How much funding has Instech Laboratories raised?
Instech Laboratories has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Instech Laboratories
PPP
Public-Private Partnership
What's next for Instech Laboratories?
The infusion of capital from this late-stage financing round is expected to catalyze Instech Laboratories' next phase of development. Strategic priorities likely include the scaling of manufacturing processes to meet rising global demand for sophisticated animal research tools and the potential expansion of their educational and training initiatives. As the company continues to refine its product suite, it remains focused on maintaining its leadership position in the laboratory equipment market. By leveraging this financial backing, Instech is poised to enhance its research support infrastructure, ensuring that it remains at the forefront of innovation in the specialized field of rodent-based biomedical experimentation.
See full Instech Laboratories company page
